Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
-.--% | -.--% |
06-07 | Russian court orders $56 mln Landesbank Baden-Wuerttemberg asset seizure | RE |
05-30 | ESAB to Acquire Linde Industries Private in Bangladesh for Undisclosed Sum | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 31.3 and 27.75 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Revenue estimates are regularly revised downwards for the current and coming years.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 210B | - | ||
+0.49% | 61.17B | A | ||
+20.31% | 12.95B | B | ||
+64.32% | 9.46B | C+ | ||
-15.78% | 3.34B | D+ | ||
+11.32% | 3.12B | C- | ||
+14.57% | 3.07B | C+ | ||
+10.72% | 2.29B | - | ||
-9.91% | 2.24B | - | ||
+3.96% | 1.66B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- 0M2B Stock
- Ratings Linde